BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33326561)

  • 1. Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.
    Butler DA; Rana AP; Krapp F; Patel SR; Huang Y; Ozer EA; Hauser AR; Bulman ZP
    J Antimicrob Chemother; 2021 Feb; 76(3):671-679. PubMed ID: 33326561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing
    Huang Y; Sokolowski K; Rana A; Singh N; Wang J; Chen K; Lang Y; Zhou J; Kadiyala N; Krapp F; Ozer EA; Hauser AR; Li J; Bulitta JB; Bulman ZP
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0069221. PubMed ID: 34152820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
    Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains.
    Demirbas Z; Ozger HS; Suzuk-Yildiz S; Bakkaloglu Z; Dizbay M
    Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    Huang Y; Rana AP; Wenzler E; Ozer EA; Krapp F; Bulitta JB; Hauser AR; Bulman ZP
    J Antimicrob Chemother; 2022 Feb; 77(2):356-363. PubMed ID: 34668007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum β-Lactamases Collected in Two Multicenter Studies in Spain.
    Fernández-Martínez M; Ruiz Del Castillo B; Lecea-Cuello MJ; Rodríguez-Baño J; Pascual Á; Martínez-Martínez L;
    Microb Drug Resist; 2018 May; 24(4):367-376. PubMed ID: 29727265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KPC-producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistance to amikacin.
    Bremmer DN; Clancy CJ; Press EG; Almaghrabi R; Chen L; Doi Y; Nguyen MH; Shields RK
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7597-600. PubMed ID: 25288089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.
    Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance.
    Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M;
    BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
    Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
    J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside resistance determinants in multiresistant
    Cirit OS; Fernández-Martínez M; Yayla B; Martínez-Martínez L
    Acta Microbiol Immunol Hung; 2019 Sep; 66(3):327-335. PubMed ID: 30803254
    [No Abstract]   [Full Text] [Related]  

  • 12. Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.
    Lindemann PC; Risberg K; Wiker HG; Mylvaganam H
    APMIS; 2012 Jun; 120(6):495-502. PubMed ID: 22583362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside susceptibility profiles of Enterobacter cloacae isolates harboring the aac(6')-Ib gene.
    Kim SY; Park YJ; Yu JK; Kim YS
    Korean J Lab Med; 2011 Oct; 31(4):279-81. PubMed ID: 22016682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
    J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
    Murray BE; Moellering RC
    Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates co-harbouring aminoglycoside-modifying enzymes, bla
    Firmo EF; Oliveira Júnior JB; Scavuzzi AML; Alves LC; Brayner FA; Veras DL; Lopes ACS
    J Glob Antimicrob Resist; 2020 Sep; 22():511-514. PubMed ID: 32344124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis of enzymatic resistance of E. coli to aminoglycosides.
    Ojdana D; Sieńko A; Sacha P; Majewski P; Wieczorek P; Wieczorek A; Tryniszewska E
    Adv Med Sci; 2018 Mar; 63(1):9-13. PubMed ID: 28763677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases].
    Díaz PQ; Bello HT; Domínguez MY; Trabal NF; Mella SM; Zemelman RZ; González GR
    Rev Med Chil; 2004 Oct; 132(10):1173-8. PubMed ID: 15631204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of the Novel Aminoglycoside Acetyltransferase Variant
    Sato T; Wada T; Nishijima S; Fukushima Y; Nakajima C; Suzuki Y; Takahashi S; Yokota SI
    mBio; 2020 Dec; 11(6):. PubMed ID: 33443109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.